MEDVi vs Zealthy: Which GLP-1 Provider Is Better?
A side-by-side comparison of MEDVi and Zealthy covering pricing, scores, medication types, insurance, and more to help you decide.
MEDVi
#9 of 31Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViZealthy
#26 of 31Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.
Visit Zealthy| Feature | MEDVi | Zealthy |
|---|---|---|
| Our Score | 8.3/10 | 7.6/10 |
| Starting Price | $179/mo | $151/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users who want the option to switch between compounded and brand-name GLP-1s |
| Ranking | #9 | #26 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Zealthy
Pros
- +Flexibility to switch meds
- +Both types available
- +Competitive pricing
- +Good flexibility
Cons
- −No insurance
- −Newer platform
Our Verdict
MEDVi edges out Zealthy with a score of 8.3/10 vs 7.6/10. If budget is your priority, Zealthy starts at $151/mo compared to MEDVi's $179/mo. Zealthy offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Zealthy if you want: users who want the option to switch between compounded and brand-name glp-1s.